Epstein-barr virus nuclear antigen 1 sequences in endemic and sporadic Burkitt's lymphoma reflect virus strains prevalent in different geographic areas.
about
Epstein-barr virus sequence variation-biology and diseaseMolecular evolution of the gamma-Herpesvirinae.Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis.Genome-wide analysis of wild-type Epstein-Barr virus genomes derived from healthy individuals of the 1,000 Genomes Project.EBNA1 and LMP1 variants in multiple sclerosis cases and controls.Quantitative studies of Epstein-Barr virus-encoded microRNAs provide novel insights into their regulation.Unexpected patterns of Epstein-Barr virus transcription revealed by a high throughput PCR array for absolute quantification of viral mRNA.Functional modulation of the metastatic suppressor Nm23-H1 by oncogenic virusesEpstein-Barr virus genetic variation in lymphoblastoid cell lines derived from Kenyan pediatric population.Sequence Variation Analysis of Epstein-Barr Virus Nuclear Antigen 1 Gene in the Virus Associated Lymphomas of Northern ChinaIdentifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis.Detection of nasopharyngeal carcinoma in Morocco (North Africa) using a multiplex methylation-specific PCR biomarker assay.Genome-wide analysis of Epstein-Barr virus (EBV) isolated from EBV-associated gastric carcinoma (EBVaGC).Identification of a novel variant of LMP-1 of EBV in patients with endemic Burkitt lymphoma in western KenyaThe extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal.Epstein-Barr virus utilizes Ikaros in regulating its latent-lytic switch in B cells.Different patterns of Epstein-Barr virus latency in endemic Burkitt lymphoma (BL) lead to distinct variants within the BL-associated gene expression signature.Methylation of transcription factor binding sites in the Epstein-Barr virus latent cycle promoter Wp coincides with promoter down-regulation during virus-induced B-cell transformation.Novel intertypic recombinants of epstein-barr virus in the chinese population.Cytotoxic T-lymphocyte responses to a polymorphic Epstein-Barr virus epitope identify healthy carriers with coresident viral strainsDifferential immunogenicity of Epstein-Barr virus latent-cycle proteins for human CD4(+) T-helper 1 responses.Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.EBNA-1 sequences in endemic and sporadic Burkitt's lymphoma.EBNA1: Oncogenic Activity, Immune Evasion and Biochemical Functions Provide Targets for Novel Therapeutic Strategies against Epstein-Barr Virus- Associated Cancers.Sequence Variation of Epstein-Barr Virus: Viral Types, Geography, Codon Usage, and Diseases
P2860
Q54749163-6E6148CD-33CE-44C8-A6B6-2543C50681A3Q54749947-EEC680FB-2EC7-48E3-9B48-91B0081E8386Q54833018-611F3587-D977-4914-8302-DDB5128698F5Q54835437-C4316431-B6F2-4D50-B29B-F817292CB8D9Q54835945-C1AF64B7-6C5C-4CBB-A4D2-5BD6B7AC977FQ54898506-FEF4219B-B8B5-432D-A564-14F8490FB3A3Q54899467-F55AFF64-3E61-483C-925A-27B7C81E896BQ54899803-D7981B89-87FB-4E38-A7B4-616EC25D6370Q54903977-597B491B-8925-4C4C-84F3-8C55BCD69E62Q54907132-E288A215-3E21-47DA-B551-B34DCE484C6CQ54952081-98B51A4E-F042-4189-8F60-4A19305FE4EAQ54995202-202C3B3B-054B-45DD-847B-ACC361508DB7
P1343
Q27003183-8F9774B2-76F8-4086-8A9B-8A72A679D034Q33772225-4B2EF664-AF6A-4D80-8DDE-D94027B9B28CQ33911843-091D4559-A4C7-4918-A720-4A3688859A27Q33925373-8BF16421-CD07-4B84-BEB2-580F34E4D103Q34249710-8108887B-DBDD-4BFB-80F3-1794675D469AQ34485302-55700783-4A7E-4782-A083-55DC4EE4877BQ34703035-52C298E5-B1E6-4881-A35F-68459F594C40Q34901718-23787A4F-48FC-42B1-88E2-0DB5ED0F6106Q35620244-FB43A701-D0E3-44C0-8D25-564564EE5239Q35804593-DBB504AE-714C-4552-8BDA-F0E97E946230Q35915780-F0FDC984-F0AF-41A3-8AB1-7FFBA701CB35Q35987088-110467E9-FA4B-43D1-AA0F-5598715010D9Q36782621-148D6C29-AE0A-4C05-B7C3-5516E7D0E2EBQ37356629-B156C073-19D3-4D2A-955F-C3CB18FFEB90Q37549340-2EE1BFC3-8C75-47EA-BF48-B144A1B50C67Q37713982-8FB8D23C-FE30-4DDE-9AE2-196A24A3B1B1Q39220424-1DFF0AE3-93EC-4EA0-BF2B-FD27D3ABAA8CQ39585366-1549F79C-2782-4B26-B644-714E81DA5202Q39588391-2D6BF603-13A9-45FD-9487-9EBE3E313EAFQ39589275-025D955C-4DAF-45DA-BFEE-683914FF6568Q39607047-ED3C9269-F2E9-43D8-A709-E4615D23EADDQ40375637-A3DA51FF-7176-4B6B-AE6F-FF55231418C7Q42753227-6965873A-D2F2-43AD-A119-E27D72B92343Q52593708-597BE157-273A-4F89-B2F4-E41CFC7C2F90Q58706090-C3EA115E-6003-48F8-8ED0-6F3E8D4CE991
P2860
Epstein-barr virus nuclear antigen 1 sequences in endemic and sporadic Burkitt's lymphoma reflect virus strains prevalent in different geographic areas.
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Epstein-barr virus nuclear ant ...... in different geographic areas.
@ast
Epstein-barr virus nuclear ant ...... in different geographic areas.
@en
type
label
Epstein-barr virus nuclear ant ...... in different geographic areas.
@ast
Epstein-barr virus nuclear ant ...... in different geographic areas.
@en
prefLabel
Epstein-barr virus nuclear ant ...... in different geographic areas.
@ast
Epstein-barr virus nuclear ant ...... in different geographic areas.
@en
P2093
P2860
P4510
P921
P1433
P1476
Epstein-barr virus nuclear ant ...... in different geographic areas
@en
P2093
P2860
P304
P577
1999-02-01T00:00:00Z